These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15952908)
1. Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Dickerson TJ; Kaufmann GF; Janda KD Expert Opin Biol Ther; 2005 Jun; 5(6):773-81. PubMed ID: 15952908 [TBL] [Abstract][Full Text] [Related]
2. Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy. Dickerson TJ; Janda KD AAPS J; 2005 Oct; 7(3):E579-86. PubMed ID: 16353936 [TBL] [Abstract][Full Text] [Related]
3. Treating cocaine addiction with viruses. Carrera MR; Kaufmann GF; Mee JM; Meijler MM; Koob GF; Janda KD Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10416-21. PubMed ID: 15226496 [TBL] [Abstract][Full Text] [Related]
5. Cocaine pharmacology and current pharmacotherapies for its abuse. Carrera MR; Meijler MM; Janda KD Bioorg Med Chem; 2004 Oct; 12(19):5019-30. PubMed ID: 15351386 [TBL] [Abstract][Full Text] [Related]
7. Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users. Brimijoin S CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):880-91. PubMed ID: 22229308 [TBL] [Abstract][Full Text] [Related]
8. Application of artificial enzymes to the problem of cocaine. De Prada P; Winger G; Landry DW Ann N Y Acad Sci; 2000; 909():159-69. PubMed ID: 10911929 [TBL] [Abstract][Full Text] [Related]
9. Positional linker effects in haptens for cocaine immunopharmacotherapy. Ino A; Dickerson TJ; Janda KD Bioorg Med Chem Lett; 2007 Aug; 17(15):4280-3. PubMed ID: 17531484 [TBL] [Abstract][Full Text] [Related]
10. Development of immunopharmacotherapy against drugs of abuse. Meijler MM; Matsushita M; Wirsching P; Janda KD Curr Drug Discov Technol; 2004 Jan; 1(1):77-89. PubMed ID: 16472221 [TBL] [Abstract][Full Text] [Related]
11. Suppression of psychoactive effects of cocaine by active immunization. Carrera MR; Ashley JA; Parsons LH; Wirsching P; Koob GF; Janda KD Nature; 1995 Dec; 378(6558):727-30. PubMed ID: 7501020 [TBL] [Abstract][Full Text] [Related]
12. Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen. Henry KA; Murira A; van Houten NE; Scott JK Bioeng Bugs; 2011; 2(5):275-83. PubMed ID: 22008640 [TBL] [Abstract][Full Text] [Related]
13. Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence. Moreno AY; Janda KD Pharmacol Biochem Behav; 2009 Apr; 92(2):199-205. PubMed ID: 19350728 [TBL] [Abstract][Full Text] [Related]
14. Novel approaches to the treatment of cocaine addiction. Sofuoglu M; Kosten TR CNS Drugs; 2005; 19(1):13-25. PubMed ID: 15651902 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of single chain anti-cocaine catalytic antibodies. McKenzie KM; Mee JM; Rogers CJ; Hixon MS; Kaufmann GF; Janda KD J Mol Biol; 2007 Jan; 365(3):722-31. PubMed ID: 17084858 [TBL] [Abstract][Full Text] [Related]
16. The Rhodococcus sp. cocaine esterase: a bacterial candidate for novel pharmacokinetic-based therapies for cocaine abuse. Ascenzi P; Clementi E; Polticelli F IUBMB Life; 2003 Jul; 55(7):397-402. PubMed ID: 14584590 [TBL] [Abstract][Full Text] [Related]
17. Filamentous bacteriophage: A prospective platform for targeting drugs in phage-mediated cancer therapy. Garg P J Cancer Res Ther; 2019 Mar; 15(Supplement):S1-S10. PubMed ID: 30900613 [TBL] [Abstract][Full Text] [Related]
18. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence. Hall W; Carter L J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512 [TBL] [Abstract][Full Text] [Related]